itraconazole and Hemorrhagic Fever, Ebola

itraconazole has been researched along with Hemorrhagic Fever, Ebola in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Goretzko, J; Kirchoff, N; Kummer, S; Lander, A; Rescher, U; Schloer, S	1

Other Studies

1 other study(ies) available for itraconazole and Hemorrhagic Fever, Ebola

Article	Year
Pharmacologically induced endolysosomal cholesterol imbalance through clinically licensed drugs itraconazole and fluoxetine impairs Ebola virus infection Emerging microbes & infections, 2022, Volume: 11, Issue:1 Topics: Antiviral Agents; Cholesterol; Ebolavirus; Endosomes; Fluoxetine; Hemorrhagic Fever, Ebola; Humans; Itraconazole; Niemann-Pick C1 Protein; Sphingomyelin Phosphodiesterase; Virus Internalization	2022

Article

Year

Pharmacologically induced endolysosomal cholesterol imbalance through clinically licensed drugs itraconazole and fluoxetine impairs Ebola virus infection

Emerging microbes & infections, 2022, Volume: 11, Issue:1

Topics: Antiviral Agents; Cholesterol; Ebolavirus; Endosomes; Fluoxetine; Hemorrhagic Fever, Ebola; Humans; Itraconazole; Niemann-Pick C1 Protein; Sphingomyelin Phosphodiesterase; Virus Internalization

2022